Positive data from the MIRANDA trial follows the OBERON and TITANIA studies of tozorakimab in COPD.

A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials, ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. After things have been stable for a long ...

(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...

COPD is a progressive respiratory condition characterised by airway obstruction, reduced lung function, and episodic symptom flare-ups. The disease affects an estimated 1.2 million people with a ...

Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading cause of death. Mucus plugging (mucus that accumulates in the lungs and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The 2026 GOLD report newly highlights disease activity ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Breathing is a seemingly simple human process that’s ...